H2Stem® cells represent another cell therapy product developed by Promethera® Biosciences. H2Stem® cells show specific characteristics and, like HepaStem™, are also derived from donated livers.
They display a high capacity for homing, in situ differentiation into hepatocytes and repopulation following their transplantation into a mouse model of human xenografts.
Promethera® Biosciences is currently optimizing the manufacturing process and performing preclinical studies to further characterize the cell type and its therapeutic potential. It is likely that H2Stem® cells will have an important role in tissue repair.